1 |
E. A. Dennis, J. Cao, Y. H. Hsu, V. Magrioti, G. Kokotos, Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention, Chem. Rev. 111, 6131, (2011).
|
2 |
D. L. Scott, S. P. White, Z. Otwinowski, W. Yuan, M. H. Gelb, P. B. Sigler, Interfacial catalysis - the mechanism of phospholipase A2, Science 250, 1541, (1990).
DOI
|
3 |
K. Wagner, G. Brezesinski, Phospholipases to recognize modelmembrane structures on a molecular length scale, Curr. Opin. Colloid Interface Sci. 13 47, (2008).
DOI
|
4 |
J. E. Burke, E. A. Dennis, Phospholipase A2 structure/function, mechanism, and signaling, J. Lipid Res. 50, S237, (2009).
DOI
|
5 |
O. G. Mouritsen, T. L. Andresen, A. Halperin, P. L. Hansen, A. F. Jakobsen, U.B. Jensen, M. O. Jensen, K. Jorgensen, T. Kaasgaard, C. Leidy, A. C. Simonsen, G. H. Peters, M. Weiss, Activation of interfacial enzymes at membrane surfaces, J. Phys. Condens. Matter 18, S1293, (2006).
DOI
|
6 |
M. H. Gelb, M. K. Jain, A. M. Hanel, O. G. Berg, Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2, Annu. Rev. Biochem. 64, 653, (1995).
DOI
|
7 |
O. Berg, M. Gelb, M.-D. Tsai, M. K. Jain, Interfacial enzymology: the secreted phospholipase paradigm, Chem. Rev. 101 2613, (2001).
DOI
|
8 |
O. Berg, B. Z. Yu, J. Rogers, M. K. Jain, Interfacial catalysis by phospholipase A2: determination of the interfacial kinetic rate constants, Biochemistry 30, 7283, (1991).
DOI
|
9 |
W. R. Burack, Q. Yuan, R. L. Biltonen, Role of lateral phase separation in the modulation of phospholipase A2 activity, Biochemistry 32, 583, (1993).
DOI
|
10 |
U. Dahmen-Levison, G. Brezesinski, H. Mohwald, Specific adsorption of PLA2 at monolayers, Thin Solid Films 327(5), 616, (1998).
|
11 |
D. W. Grainger, A. Reichert, H. Ringsdorf, C. Salesse, An enzyme caught in action: direct imaging of hydrolytic function and domain formation of phospholipase A2 in phosphatidylcholine monolayers, FEBS Lett. 252, 73, (1989).
DOI
|
12 |
G. Batist, K. A. Gelmon, K. N. Chi, W. H. Miller, S. K. L. Chia, L. D. Mayer, C. E. Swenson, Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors, Clin. Cancer Res. 15 , 692, (2009).
DOI
|
13 |
A. Chonn, S. C. Semple, P. R. Cullis, Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes, J. Biol. Chem. 267, 18759, (1992).
|
14 |
H. Maeda, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, Adv. Enzyme Regul. 41, 189, (2001).
DOI
|
15 |
A. A. Gabizon, Liposomal drug carrier systems in cancer chemotherapy: current status and future prospects, J. Drug Target. 10, 535, (2002).
DOI
|